While most doctors recommend monthly breast self - exams, it's not yet clear if the practice results in
higher survival rates overall.
Not exact matches
The researchers found that at five years, very few patients who received chemotherapy experienced disease relapses, showing
high rates of distant metastases - free
survival, disease - free
survival and
overall survival, which confirms that they derived benefit from chemotherapy.
In absolute terms, the
overall survival rate at five years was 11 %
higher in the ipilimumab arm (65 %) than in the placebo arm (54 %).
The five year disease - free and
overall survival rates for patients with
high - risk malignant germ cell tumours remains less than 50 %, and so accurate diagnosis and monitoring is crucial to improving outcomes for patients.
Patients who had surgery in sunny months — May to August — had a roughly 30 percent
higher overall survival rate or time to cancer recurrence than did those getting surgery in the winter.
In the total patient population, the 5 - year
overall survival rate was 95 %, although it was significantly
higher in non-cirrhotic (97 %) than cirrhotic patients (92 %).
But a model that incorporated both
rates showed that the mosquitoes»
overall probability of
survival is
higher at
higher temperatures.
Although CRC affects all racial and ethnic groups, African Americans carry an excessive burden of disease with the
highest overall incidence,
highest incidence of advanced stage at presentation,
highest mortality, and lowest
survival rates compared to any other ethnic or racial group.
At five - years post-treatment, patients in the HFX arm had the
highest overall survival rates at 37.1 percent (HR 0.81, 95 percent CI), compared to 33.7 percent for the AFX - C arm, 29.3 percent for the SFX arm, 29.0 percent for the AFX - S arm.
Regardless of the type of therapy, the prognosis has been a dismal reported median
overall survival of 12 - 16 months and
high rate of relapse within 1 year [1 - 3].
CPX - 351 resulted in longer
overall survival (9.56 versus 5.95 months; P = 0.005) and
higher rates of complete response (47.7 % versus 33.3 %; P = 0.016).
In five independent large cohorts in which more than 1100 total patients were followed for
overall survival (Desmedt et al., 2007; Esserman et al., 2012; Kao et al., 2011; Pawitan et al., 2005; van de Vijver et al., 2002; Supplementary file 1),
high expression level of MELK strongly correlated with increased
rates of mortality (all p values < 0.05, hazard ratios > 2)(Figure 2D, Figure 2 — figure supplement 1D).
Overall survival rates for surgical colics are 85 %, small intestinal lesions lower at 50 % to 70 % and large intestinal lesions as
high as 90 %.